前沿生物(688221.SH)：第三季度净亏损6245.59万元
Frontier Biotechnologies(SH:688221) Ge Long Hui A P P·2025-10-30 15:02Core Insights - Frontier Biotech (688221.SH) reported a revenue of 44.73 million yuan for Q3 2025, representing a year-on-year increase of 10.22% [1] - The net profit attributable to shareholders of the listed company was -62.46 million yuan [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -70.49 million yuan [1]